Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 1 , Pages 26-32 , March 2007

Molecular Carcinogenesis of Endometrial Cancer

  • Fu-Shing Liu

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr Fu-Shing Liu, Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, 160, Taichung Kang Road, Section 3, Taichung, Taiwan

,Accepted 16 August 2006.

References 

  1. Gruber SB , Thompson WD . A population-based study of endometrial cancer and familial risk in younger women: Cancer and Steroid Hormone Study Group . Cancer Epidemiol Biomarkers Prev . 1996;5:411–417
  2. Bokhman JV . Two pathogenetic types of endometrial carcinoma . Gynecol Oncol . 1983;15:10–17
  3. Potischman N , Hoover RN , Brinton LA , et al.   Case-control study of endogenous steroid hormones and endometrial cancer . J Natl Cancer Inst . 1996;88:1127–1135
  4. Lax SF , Pizer ES , Ronnett BM , Kurman RJ . Comparison of estrogen and progesterone receptor, Ki67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation . Hum Pathol . 1998;29:924–931
  5. Sherman ME , Bur ME , Kurman RJ . p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorogenesis . Hum Pathol . 1995;26:1268–1274
  6. Ambros RA , Sherman ME , Zahn CM , Bitterman P , Kurman RJ . Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation . Hum Pathol . 1995;26:1260–1267
  7. Lax SF , Pizer ES , Ronnett BM , Kurman RJ . Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression . Hum Pathol . 1998;29:551–558
  8. Mutter GL . Pten, a protean tumor suppressor . Am J Pathol . 2001;158:1895–1898
  9. Wu H , Goel V , Haluska FG . PTEN signaling pathways in melanoma . Oncogene . 2003;22:3113–3122
  10. Mutter GL , Lin MC , Fitzgerald JT , et al.   Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers . J Natl Cancer Inst . 2000;92:924–930
  11. Salvesen HB , MacDonald N , Ryan A , et al.   PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma . Int J Cancer . 2001;91:22–26
  12. Risinger JI , Hayes K , Maxwell GL , Carney ME , Barrett JC , Berchuck A . PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics . Clin Cancer Res . 1998;4:3005–3010
  13. Burks RT , Kessis TD , Cho KR , Hedrick L . Microsatellite instability in endometrial carcinoma . Oncogene . 1994;9:1163–1166
  14. Caduff RF , Johnston CM , Svoboda Newman SM , Poy EL , Merajver SD , Frank TS . Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma . Am J Pathol . 1996;148:1671–1678
  15. MacDonald ND , Salvesen HB , Ryan A , Iversen OE , Akslen LA , Jacobs IJ . Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas . Cancer Res . 2000;60:1750–1752
  16. Esteller M , Levine R , Baylin SB , Ellenson LH , Herman JG . MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas . Oncogene . 1998;17:2413–2417
  17. Salvesen HB , MacDonald N , Ryan A , et al.   Methylation of hMLH1 in a population-based series of endometrial carcinomas . Clin Cancer Res . 2000;6:3607–3613
  18. Staebler A , Lax SF , Ellenson LH . Altered expression of hMLH1 and hMSH2 protein in endometrial carcinomas with microsatellite instability . Hum Pathol . 2000;31:354–358
  19. Stefansson I , Akslen LA , MacDonald N , et al.   Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study . Clin Cancer Res . 2002;8:138–143
  20. Katabuchi H , van Rees B , Lambers AR , et al.   Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas . Cancer Res . 1995;55:5556–5560
  21. Goodfellow PJ , Buttin BM , Herzog TJ , et al.   Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers . Proc Natl Acad Sci USA . 2003;100:5908–5913
  22. Maxwell GL , Risinger JI , Alvarez AA , Barrett JC , Berchuck A . Favorable survival associated with microsatellite instability in endometrioid endometrial cancers . Obstet Gynecol . 2001;97:417–422
  23. Caduff RF , Johnston CM , Frank TS . Mutations of the Ki-ras oncogene in carcinoma of the endometrium . Am J Pathol . 1995;146:182–188
  24. Semczuk A , Schneider-Stock R , Berbec H , Marzec B , Jakowicki JA , Roessner A . K-ras exon 2 point mutations in human endometrial cancer . Cancer Lett . 2001;164:207–212
  25. Sasaki H , Nishii H , Takahashi H , et al.   Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma . Cancer Res . 1993;53:1906–1910
  26. Lagarda H , Catasus L , Arguelles R , Matias-Guiu X , Prat J . K-ras mutation in endometrial carcinoma with microsatellite instability . J Pathol . 2001;193:193–199
  27. Ikeda T , Yoshinaga K , Suzuki A , Sakurada A , Ohmori H , Horii A . Anticorresponding mutations of the KRAS and PTEN genes in human endometrial cancer . Oncol Res . 2000;7:567–570
  28. Saegusa M , Hashimura M , Yoshida T , Okayasu I . Betacatenin mutations and aberrant nuclear expression during endometrial tumorigenesis . Br J Cancer . 2001;84:209–217
  29. Logan CY , Nusse R . The Wnt signaling pathway in development and disease . Annu Rev Cell Dev Biol . 2004;20:781–810
  30. Palacios J , Catasus L , Moreno Bueno G , Matias Guiu X , Prat J , Gamallo C . Betaand gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability . Virchows Arch . 2001;438:464–469
  31. Strauli P , Haemmerli G . The role of cancer cell motility in invasion . Cancer Metastasis Rev . 1984;3:127–141
  32. Volk T , Geiger B , Raz A . Motility and adhesive properties of high and low-metastatic murine neoplastic cells . Cancer Res . 1984;44:811–824
  33. Holcomb K , Delatorre R , Pedemonte B , McLeod C , Anderson L , Chambers J . E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium . Obstet Gynecol . 2002;100:1290–1295
  34. Mell LK , Meyer JJ , Tretiakova M , et al.   Prognostic significance of E-cadherin protein expression in pathological stage I–III endometrial cancer . Clin Cancer Res . 2004;10:5546–5553
  35. Scholten AN , Aliredjo R , Creutzberg CL , Smit VT . Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma . Int J Gynecol Cancer . 2006;16:1379–1385
  36. Salvesen HB , Das S , Akslen LA . Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis . Clin Cancer Res . 2000;6:153–159
  37. Milde-Langosch K , Riethdorf L , Bamberger AM , Loning T . P16/MTS1 and pRB expression in endometrial carcinomas . Virchows Arch . 1999;434:23–28
  38. Tsuda H , Yamamoto K , Inoue T , Uchiyama I , Umesaki N . The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma . Br J Cancer . 2000;82:675–682
  39. Yanokura M , Banno K , Susumu N , et al.   Hypermethyltion in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients . Anticancer Res . 2006;26:851–856
  40. Salvesen HB , Kumar R , Stefansson I , et al.   Low frequency of BRAF and CDKN2A mutations in endometrial cancer . Int J Cancer . 2005;115:930–934
  41. Lax SF , Kendall B , Tashiro H , Slebos RJ , Hedrick L . The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways . Cancer . 2000;88:814–824
  42. Koul A , Willen R , Bendahl PO , Nilbert M , Borg A . Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis . Cancer . 2002;94:2369–2379
  43. Ioffe OB , Papadimitriou JC , Drachenberg CB . Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium . Hum Pathol . 1998;29:1150–1159
  44. Williams JA , Wang ZR , Parrish RS , Hazlett LJ , Smith ST , Young SR . Fluorescence in situ hybridization analysis of FER2/neu, c-myc, and p53 in endometrial cancer . Exp Mol Pathol . 1999;67:135–143
  45. Matias-Guiu X , Catasus L , Bussaglia E , et al.   Molecular pathology of endometrial hyperplasia and carcinoma . Hum Pathol . 2001;32:569–577
  46. Lax SF . Molecular genetic pathways in various types of endometrioid carcinoma: from a phenotypical to a molecularbased classification . Virchows Arch . 2004;444:213–223
  47. Dong JT , Lamb PW , Rinker-Schaeffer CW , et al.   KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 . Science (Washington DC) . 1995;268:884–886
  48. Liu FS , Dong JT , Chen JT , et al.   KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer . Clin Cancer Res . 2003;9:1393–1398
  49. Liu FS , Chen JT , Hsieh YT , et al.   Loss of Smad4 protein expression occurs infrequently in endometrial carcinomas . Int J Gynecol Pathol . 2003;22:347–352
  50. Piestrzeniewicz-Ulanska D , Brys M , Semczuk A , Rechberger T , Jakowicki JA , Krajewska WM . TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas . Gynecol Oncol . 2004;95:173–180
  51. Tashiro H , Isacson C , Levine R , Kurman RJ , Cho KR , Hedrick L . p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis . Am J Pathol . 1997;150:177–185
  52. Tashiro H , Blazes MS , Wu R , et al.   Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies . Cancer Res . 1997;57:3935–3940
  53. Tashiro H , Lax SF , Gaudin pb , Isacson C , Cho KR , Hedrick L . Microsatellite instability is uncommon in uterine serous carcinoma . Am J Pathol . 1997;150:75–79
  54. Catasus L , Machin P , Matias Guiu X , Prat J . Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases . Hum Pathol . 1998;29:1160–1164
  55. Halperin R , Zehavi S , Habler L , Hadas E , Bukovsky I , Schneider D . Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium . Eur J Gynaecol Oncol . 2001;22:122–126
  56. Rolitsky CD , Theil KS , McGaughy VR , Copeland LJ , Niemann TH . HER-2/neu amplification and overexpression in endometrial carcinoma . Int J Gynecol Pathol . 1999;18:138–143
  57. Moreno-Bueno G , Hardisson D , Sarrio D , et al.   Abnormalities of Eand P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia . J Pathol . 2003;199:471–478
  58. Schlosshauer PW , Ellenson LH , Soslow RA . Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype . Mod Pathol . 2002;15:1032–1037
  59. Lax SF , Abeler VM , Regitnig P . Molecular genetic analysis of endometrial carcinoma: evidence for 2 genetically distinctive entities . Virchows Arch . 2001;439:247–252
  60. Ho ESC , Lai CR , Hsieh YT , Chen JT , Hung MJ , Liu FS . p53 mutation is infrequent in clear cell carcinoma of the ovary . Gynecol Oncol . 2001;80:189–193
  61. Zorn KK , Bonome T , Gangi L , et al.   Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer . Clin Cancer Res . 2005;11:6422–6430
  62. Kanaya T , Kyo S , Maida Y , et al.   Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers . Oncogene . 2003;22:2352–2360
  63. Lynch HT , Smyrk TC , Watson P , et al.   Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review . Gastroenterology . 1993;104:1535–1549
  64. Watson P , Vasen HF , Mecklin JP , Jarvinen H , Lynch HT . The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer . Am J Med . 1994;96:516–520
  65. Vasen HF , Watson P , Mecklin JP , et al.   The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer . Anticancer Res . 1994;14:1675–1678
  66. Peltomaki P , Vasen HF . The International Collaborative Group on HNPCC. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study . Gastroenterology . 1997;113:1146–1158
  67. Miyaki M , Konishi M , Tanaka K , et al.   Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer . Nat Genet . 1997;17:271–272
  68. Schweizer P , Moisio AL , Kuismanen SA , et al.   Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer . Cancer Res . 2001;61:2813–2815
  69. Parc YR , Halling KC , Burgart LJ , et al.   Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: association with family history and histopathology . Int J Cancer . 2000;86:60–66
  70. de Leeuw WJ , Dierssen J , Vasen HF , et al.   Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumors from HNPCC patients . J Pathol . 2000;192:328–335
  71. Sandles LG . Familial endometrial adenocarcinoma . Clin Obstet Gynecol . 1998;41:167–171
  72. Ollikainen M , Abdel-Rahman WM , Moisio AL , et al.   Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? . J Clin Oncol . 2005;23:4609–4616
  73. Risinger JI , Maxwell GL , Chandramouli GV , et al.   Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer . Cancer Res . 2003;63:6–11

PII: S1028-4559(08)60102-3

doi: 10.1016/S1028-4559(08)60102-3

Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 1 , Pages 26-32 , March 2007

Article Tools